1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine zwitterion

Metabolite details

Identifier

MPWUZHVZZKSTPV-MADBQMNMSA-N

InChI Key

MPWUZHVZZKSTPV-MADBQMNMSA-N

IUPAC name

2-azaniumylethyl (2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(hexadecanoyloxy)propyl phosphate

Preferred name

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine zwitterion

INN name

—

Synonym

PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

ChEBI

CHEBI:78261

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• Metabolic changes associated with tick-microbe interactions

Observed in differential profiles

• Wild_type_vs_hfq
• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Plasma_vs_WY-14,643_Plasma
• Control_vs_AONFH_Stage_III_IV
• WT_vs_WT_Aco
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• MCF-7_WT_vs_MCF-7_PKM2_KO
• Knockdown_vs_Control
• Knockdown_vs_Control
• G1_Ctrl_vs_G2_Ab
• Uninfected_1h_vs_Anaplasma_phagocytophilum_1h